These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 19694503

  • 1. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J, Minayian M, Moazen E.
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [Abstract] [Full Text] [Related]

  • 2. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
    Varshosaz J, Tabbakhian M, Mohammadi MY.
    J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
    [Abstract] [Full Text] [Related]

  • 3. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L, Tang X, Cui F.
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [Abstract] [Full Text] [Related]

  • 4. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
    Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU.
    Colloids Surf B Biointerfaces; 2012 Sep 01; 97():109-16. PubMed ID: 22609590
    [Abstract] [Full Text] [Related]

  • 5. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z, Xie S, Zhu L, Wang Y, Wang X, Zhou W.
    Drug Deliv; 2011 Aug 01; 18(6):441-50. PubMed ID: 21554156
    [Abstract] [Full Text] [Related]

  • 6. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
    Hu L, Jia H, Luo Z, Liu C, Xing Q.
    Pharmazie; 2010 Feb 01; 65(2):110-3. PubMed ID: 20225654
    [Abstract] [Full Text] [Related]

  • 7. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N, Janga KY.
    Drug Dev Ind Pharm; 2017 Jul 01; 43(7):1205-1214. PubMed ID: 28274147
    [Abstract] [Full Text] [Related]

  • 8. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y.
    Int J Pharm; 2012 Jul 01; 430(1-2):238-46. PubMed ID: 22465546
    [Abstract] [Full Text] [Related]

  • 9. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N, Veerabrahma K.
    Eur J Pharm Biopharm; 2017 Jan 01; 110():47-57. PubMed ID: 27810472
    [Abstract] [Full Text] [Related]

  • 10. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA, Alshehri S, Ibrahim MA, Tawfeek HM, Razik JA, Hassan YA, Shakeel F.
    AAPS PharmSciTech; 2018 May 01; 19(4):1712-1719. PubMed ID: 29532427
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K, Venkateswarlu V.
    J Control Release; 2005 Oct 03; 107(2):215-28. PubMed ID: 16014318
    [Abstract] [Full Text] [Related]

  • 12. Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization.
    Morsi NM, Ghorab DM, Badie HA.
    Pharm Dev Technol; 2013 Oct 03; 18(3):736-44. PubMed ID: 23477526
    [Abstract] [Full Text] [Related]

  • 13. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK, Chede R, Komuravelli R, Adepu L, Sistla R, Diwan PV.
    Colloids Surf B Biointerfaces; 2012 Jun 15; 95():1-9. PubMed ID: 22463845
    [Abstract] [Full Text] [Related]

  • 14. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM, El Komy MH, Ali AA, El Menshawe SF, Abd Elbary A.
    AAPS PharmSciTech; 2016 Dec 15; 17(6):1353-1365. PubMed ID: 26743643
    [Abstract] [Full Text] [Related]

  • 15. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies.
    Shah M, Chuttani K, Mishra AK, Pathak K.
    Drug Dev Ind Pharm; 2011 May 15; 37(5):526-37. PubMed ID: 21128704
    [Abstract] [Full Text] [Related]

  • 16. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
    Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP.
    Nanomedicine; 2009 Jun 15; 5(2):184-91. PubMed ID: 19095502
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N, Veerabrahma K.
    Drug Dev Ind Pharm; 2015 Jun 15; 41(12):1968-77. PubMed ID: 25830370
    [Abstract] [Full Text] [Related]

  • 18. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N, Veerabrahma K.
    Drug Deliv; 2016 Jun 15; 23(2):395-404. PubMed ID: 24865287
    [Abstract] [Full Text] [Related]

  • 19. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.
    Pandita D, Ahuja A, Lather V, Benjamin B, Dutta T, Velpandian T, Khar RK.
    AAPS PharmSciTech; 2011 Jun 15; 12(2):712-22. PubMed ID: 21637945
    [Abstract] [Full Text] [Related]

  • 20. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H, Tang J, Li M, Ren J, Zheng N, Wu L.
    Drug Deliv; 2016 Jun 15; 23(2):459-70. PubMed ID: 24892628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.